All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Wed 1984-11-07? to Wed 2025-06-18 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| TEVA × |
−22.60%
2025-06-18 |
420.2 TR
2025-06-18 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Wed 1984-11-07? to Wed 2025-06-18 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+41,919.70%
+16.04%/yr |
+12.21%/yr
(R2=0.600) |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Wed 1984-11-07? to Wed 2025-06-18 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| TEVA × |
$10,000.00
1984-11-07 |
$4,201,970.44
2025-06-18 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Year | TEVA |
|---|---|
| 2025 (YTD) | −22.60% |
| 2024 | +111.11% |
| 2023 | +14.47% |
| 2022 | +13.86% |
| 2021 | −16.99% |
| 2020 | −1.53% |
| 2019 | −36.45% |
| 2018 | −18.63% |
| 2017 | −45.96% |
| 2016 | −43.20% |
| 2015 | +16.71% |
| 2014 | +47.36% |
| 2013 | +10.91% |
| 2012 | −5.14% |
| 2011 | −21.04% |
| 2010 | −5.90% |
| 2009 | +33.62% |
| 2008 | −7.36% |
| 2007 | +50.98% |
| 2006 | −27.12% |
| 2005 | +45.25% |
| 2004 | +6.04% |
| 2003 | +47.90% |
| 2002 | +25.98% |
| 2001 | −15.50% |
| 2000 | +106.82% |
| 1999 | +77.01% |
| 1998 | −13.45% |
| 1997 | −5.42% |
| 1996 | +9.46% |
| 1995 | +94.20% |
| 1994 | −18.61% |
| 1993 | +38.40% |
| 1992 | +133.91% |
| 1991 | +65.73% |
| 1990 | −0.83% |
| 1989 | +73.43% |
| 1988 | +10.71% |
| 1987 | −2.49% |
| 1986 | +124.62% |
| 1985 | +178.60% |
| 1984 | +5.91% |
| Wed 1984-11-07? to Wed 2025-06-18 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| TEVA × | −74.53% |
−90.80%
2019-08-15 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||